Adage Capital Partners’s Roivant Sciences ROIV Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$354M	Buy	12,794,097 +2,116,203	+20%	+$54.4M	0.55%	26
2025 Q4	$232M	Buy	10,677,894 +3,445,511	+48%	+$68M	0.35%	44
2025 Q3	$109M	Buy	7,232,383 +5,150,000	+247%	+$63.8M	0.17%	114
2025 Q2	$23.5M	Sell	2,082,383 -1,737,600	-45%	-$18.8M	0.04%	401
2025 Q1	$38.5M	Sell	3,819,983 -1,900,000	-33%	-$20.5M	0.07%	284
2024 Q4	$67.7M	Sell	5,719,983 -34,752	-0.6%	-$411K	0.12%	169
2024 Q3	$66.4M	Buy	5,754,735 +1,819,983	+46%	+$20.7M	0.12%	187
2024 Q2	$41.6M	Hold	3,934,752	–	–	0.08%	249
2024 Q1	$41.5M	Sell	3,934,752 -1,340,248	-25%	-$14.5M	0.08%	270
2023 Q4	$59.2M	Sell	5,275,000 -925,000	-15%	-$9.01M	0.12%	175
2023 Q3	$72.4M	Sell	6,200,000 -4,890,300	-44%	-$55.3M	0.16%	142
2023 Q2	$112M	Sell	11,090,300 -3,790,625	-25%	-$33.9M	0.24%	97
2023 Q1	$110M	Buy	14,880,925 +5,882,486	+65%	+$48.4M	0.25%	98
2022 Q4	$71.9M	Buy	8,998,439 +5,298,439	+143%	+$29.5M	0.17%	145
2022 Q3	$11.9M	Buy	3,700,000 +2,700,000	+270%	+$10.5M	0.03%	588
2022 Q2	$4.07M	Buy	+1,000,000	New	+$3.97M	0.01%	823